Clinical Trial Update: Sirolimus as Secondary Therapy in Chronic Graft-Versus-Host Disease Not Responding To Prior Treatment [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sirolimus as a secondary therapy for chronic graft-versus-host disease not responding to prior treatment; the study is completed with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Graft Versus Host Disease | Phase 2 | Status: COMPLETED | Results posted: 2017-05-12